Physician profile
Andrew E Nash
NPI 1326158791
$2,676.91
in general payments reported to CMS, 2019-2025
20 companies · $160 in 2025
The $160 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $655 · 2021: $708 · 2022: $231 · 2023: $39.33 · 2024: $68.19 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $652.72 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $446.57 | 2019-2022 | |
| Lilly USA, LLC | $346.27 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $319.44 | 2019-2025 | Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $296.54 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $131.13 | 2019-2022 | |
| Astellas Pharma US INC | $108.39 | 2019-2021 | |
| Abbott Laboratories | $53.23 | 2021 | |
| Gilead Sciences, INC. | $45.64 | 2020-2021 | |
| Allergan, INC. | $45.30 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $34.80 | 2021 | |
| Amarin Pharma, INC. | $31.80 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.24 | 2019 | |
| Merck Sharp & Dohme LLC | $26.46 | 2019-2021 | |
| Abbvie INC. | $22.57 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $18.18 | 2022 | |
| Amgen INC. | $18.05 | 2019 | |
| Philips North America LLC | $17.69 | 2021 | |
| Dynavax Technologies Corporation | $16.32 | 2020 | |
| Glaxosmithkline, LLC. | $14.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Nash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.